DE60119715D1 - Zusammensetzung zur prävention kardiovaskulärer erkrankungen - Google Patents
Zusammensetzung zur prävention kardiovaskulärer erkrankungenInfo
- Publication number
- DE60119715D1 DE60119715D1 DE60119715T DE60119715T DE60119715D1 DE 60119715 D1 DE60119715 D1 DE 60119715D1 DE 60119715 T DE60119715 T DE 60119715T DE 60119715 T DE60119715 T DE 60119715T DE 60119715 D1 DE60119715 D1 DE 60119715D1
- Authority
- DE
- Germany
- Prior art keywords
- prevention
- formulation
- composition
- cardiovascular diseases
- cardiovascular disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0008791A GB2361185A (en) | 2000-04-10 | 2000-04-10 | Pharmaceutical formulation for the prevention of cardiovascular disease |
GB0008791 | 2000-04-10 | ||
GB0100548A GB2361186B (en) | 2000-04-10 | 2001-01-09 | Formulation for the prevention of cardiovascular disease |
GB0100548 | 2001-01-09 | ||
PCT/GB2001/001618 WO2001076632A1 (en) | 2000-04-10 | 2001-04-10 | Formulation for the prevention of cardiovascular disease |
EP01919650.0A EP1272220B2 (de) | 2000-04-10 | 2001-04-10 | Zusammensetzung zur prävention kardiovaskulärer erkrankungen |
Publications (3)
Publication Number | Publication Date |
---|---|
DE60119715D1 true DE60119715D1 (de) | 2006-06-22 |
DE60119715T2 DE60119715T2 (de) | 2007-03-15 |
DE60119715T3 DE60119715T3 (de) | 2016-12-08 |
Family
ID=26244072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60119715.1T Expired - Lifetime DE60119715T3 (de) | 2000-04-10 | 2001-04-10 | Zusammensetzung zur prävention kardiovaskulärer erkrankungen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1272220B2 (de) |
AT (1) | ATE326240T2 (de) |
AU (1) | AU4671101A (de) |
CA (1) | CA2406077C (de) |
CY (1) | CY1105127T1 (de) |
DE (1) | DE60119715T3 (de) |
DK (1) | DK1272220T4 (de) |
ES (1) | ES2263604T5 (de) |
PT (1) | PT1272220E (de) |
WO (1) | WO2001076632A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
DE10222326A1 (de) * | 2002-05-16 | 2003-12-04 | Hexal Ag | Stabile pharmazeutische Formulierung für eine Kombination aus einem Statin mit einem ACE-Hemmer |
PL377344A1 (pl) | 2003-01-31 | 2006-01-23 | Sankyo Company, Limited | Lekarstwo do profilaktyki i leczenia miażdżycy tętnic i nadciśnienia |
EP1648422A4 (de) * | 2003-07-28 | 2007-09-19 | Reddys Lab Inc Dr | Behandlung und prävention von kardiovaskulären ereignissen |
EP2275106A1 (de) | 2005-09-15 | 2011-01-19 | Otsuka Pharmaceutical Co., Ltd. | Arzneikombination mit probucol und einem tetrazolylalkoxy-dihydrocarbostyril-derivat mit superoxid-unterdrückenden wirkungen |
US20070185065A1 (en) * | 2006-02-03 | 2007-08-09 | Vikramjit Chhokar | Combination therapy for coronary artery disease |
ES2300188B1 (es) * | 2006-05-24 | 2009-05-01 | Ferrer Internacional, S.A. | Comprimido bicapa para la prevencion de los accidentes cardiovasculares. |
MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CN101590240B (zh) * | 2008-05-30 | 2012-04-25 | 北京奥萨医药研究中心有限公司 | 含血管紧张素ⅱ受体拮抗剂、他汀和叶酸的组合物及用途 |
CN101590239B (zh) * | 2008-05-30 | 2013-03-27 | 北京奥萨医药研究中心有限公司 | 含有利尿剂、他汀和叶酸的药物组合物及其用途 |
ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US9789187B2 (en) | 2009-02-11 | 2017-10-17 | Cadila Pharmaceuticals Limited | Stable pharmaceutical composition for atherosclerosis |
EP2958577A2 (de) | 2013-02-25 | 2015-12-30 | Synergy Pharmaceuticals Inc. | Guanylat-cyclase-rezeptoragonisten zur verwendung bei der darmreinigung |
EP2970384A1 (de) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonisten der guanylatcyclase und deren verwendungen |
US10369156B2 (en) | 2016-11-15 | 2019-08-06 | The George Institute for Global Health | Compositions for the treatment of hypertension |
JP2020506180A (ja) | 2017-01-25 | 2020-02-27 | ザ ジョージ インスティテュート フォー グローバル ヘルス | 高血圧症の処置のための組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948443A (en) † | 1996-02-23 | 1999-09-07 | Medical Doctor's Research Institute, Inc. | Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease |
AU732465B2 (en) * | 1996-04-17 | 2001-04-26 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
EP0946178A4 (de) * | 1996-09-18 | 2003-05-07 | Merck & Co Inc | Kombinationstherapie zur verminderung der mit herz-kreislauferkrankungen einhergergenden risiken |
US6008221A (en) * | 1996-11-06 | 1999-12-28 | Bristol-Myers Squibb Company | Method for treating Alzheimer's disease with folic acid |
US6054128A (en) † | 1997-09-29 | 2000-04-25 | Wakat; Diane | Dietary supplements for the cardiovascular system |
-
2001
- 2001-04-10 AU AU46711/01A patent/AU4671101A/en not_active Abandoned
- 2001-04-10 WO PCT/GB2001/001618 patent/WO2001076632A1/en active IP Right Grant
- 2001-04-10 EP EP01919650.0A patent/EP1272220B2/de not_active Expired - Lifetime
- 2001-04-10 CA CA2406077A patent/CA2406077C/en not_active Expired - Fee Related
- 2001-04-10 ES ES01919650.0T patent/ES2263604T5/es not_active Expired - Lifetime
- 2001-04-10 DK DK01919650.0T patent/DK1272220T4/en active
- 2001-04-10 PT PT01919650T patent/PT1272220E/pt unknown
- 2001-04-10 DE DE60119715.1T patent/DE60119715T3/de not_active Expired - Lifetime
- 2001-04-10 AT AT01919650T patent/ATE326240T2/de active
-
2006
- 2006-08-07 CY CY20061101104T patent/CY1105127T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1105127T1 (el) | 2009-11-04 |
CA2406077C (en) | 2010-07-20 |
ES2263604T3 (es) | 2006-12-16 |
ES2263604T5 (es) | 2017-02-07 |
ATE326240T2 (de) | 2006-06-15 |
DK1272220T3 (da) | 2006-09-25 |
DK1272220T4 (en) | 2016-11-28 |
DE60119715T2 (de) | 2007-03-15 |
EP1272220A1 (de) | 2003-01-08 |
DE60119715T3 (de) | 2016-12-08 |
EP1272220B1 (de) | 2006-05-17 |
EP1272220B2 (de) | 2016-07-27 |
WO2001076632A1 (en) | 2001-10-18 |
CA2406077A1 (en) | 2001-10-18 |
PT1272220E (pt) | 2006-10-31 |
AU4671101A (en) | 2001-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE326240T2 (de) | Zusammensetzung zur prävention kardiovaskulärer erkrankungen | |
NO952863D0 (no) | Fluoxetin-farmasöytiske sammensetninger | |
EE200400020A (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
NO20055941L (no) | Anvendelse av en sammensetning omfattende en PDE4-inhibitor og en PDE5-inhibitor | |
NO20053143L (no) | Farmasoytiske sammensetninger omfattende en basisk, henholdsvis sur legemiddelforbindelse, en sufaktant og en fysiologisk akseptabel vannloselig syre henholdsvis base. | |
MY136707A (en) | Thrombopoietin mimetics | |
BG66080B1 (bg) | Заместени тиоацетамиди | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
WO2003000200A3 (en) | β-2'-OR 3'-HALONUCLEOSIDES | |
ATE396697T1 (de) | Zuckerlacton enthaltende zusammensetzung zur haarbehandlung | |
HUP0303656A2 (hu) | Bruton-féle tirozin kináz modulátorai és Bruton-féle tirozin kináz intermedierek, és eljárások azonosításukra és alkalmazásuk oszteoporózis és rokon betegségek kezelésére és prevenciójára | |
DK1341524T3 (da) | Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel | |
WO2005018605A3 (en) | Novel formulation of ropinirole | |
DE60213283D1 (de) | Pharmazeutische zusammensetzung enthaltend magermilchpulver | |
PT1682162E (pt) | Utilização de opuntia para a produção de um medicamento para o tratamento da depressão | |
ATE481971T1 (de) | Formulierung von 3-amino-8-(1-piperazinyl)-2h- 1benzopyran-2-on mit verzögerter freisetzung | |
FR2809725B1 (fr) | Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant | |
DE60122764D1 (de) | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen | |
UA40222A (uk) | Магносгель для лікування гіперінтоксикації у дітей та дорослих та спосіб його одержання | |
GR1004963B (el) | Θεραπευτικο προιον μιγμα αποξηραμενης κανελας και γαρυφαλου και μεθοδος παρασκευης του | |
EP1586556A3 (de) | Verbindungen zur Behandlung der Alzheimerischen Krankheit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |